Protective effect of crude Curcuma longa and its methanolic extract in alloxanized rabbits

Pakistan Journal of Pharmaceutical Sciences

Volumn 27, Issue 1, 2014, Pages 121-128

  Ahmad, Mobasher ^a   Kamran, Sairah Hafeez ^a   Mobasher, Afroze ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

Alloxan; Antidiabetic; Antioxidant; Curcoma longa; Hepatoprotective

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOXAN; ANTIDIABETIC AGENT; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CURCUMA LONGA EXTRACT; GASTROINTESTINAL AGENT; GLUCOSE; METHANOL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CURCUMA LONGA; DIABETES MELLITUS; DIABETOGENESIS; GLUCOSE BLOOD LEVEL; LIVER PROTECTION; MALE; NONHUMAN; RABBIT; SUSPENSION;

EID: 84893110610     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Araújo CAC and Leon LL (2001). Biological activities of Curcuma longa L. Mem Ins Oswaldo Cruz. Rio. de Janerio, 96(5): 723-728.
2. Arun N and Nalini N (2000). Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plants Foods Hum. Nutr., 57(1): 41-52.
3. Chempakam B and Parthasarathy VA (2008). Turmeric. In: Chemistry of Spices, 6th Ed., pp.97-123.
4. Heikkila RE, Winston B, Cohen G and Barden H (1976). Alloxan induced diabetes, evidence for hydroxyl radicals as a cytotoxic intermediate. Biochem. Pharmacol., 25: 1085-1092.
5. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S and Cosic V (2001). Method for the measurement of antioxidant activity in human fluids. J. Clin. Pathol., 54: 356-361.
6. Lekshmi PC, Arimboor R, Raghu KG and Menon AN (2011). Turmerin, the antioxidant protein from turmeric (Curcuma longa) exhibits antihyperglycaemic effects. Nat. Prod. Res., 1-5, iFirst.
7. (Nat. Prod. Res. 2012; 26(17): 1654-1658. doi:10.1080/14786419.2011. 589386.Epub 2011 Oct 6)
8. Lenzen S (2008). The mechanisms of alloxan and streptozotocin-induced diabetes. Diabetologia., 51: 216-226.
9. Lenzen S, Tiedge M, Jorns A and Munday R (1996). Alloxan derivatives as a tool for the elucidation of the mechanism of the diabetogenic action of alloxan. In: Lessons from Animal Diabetes VI, Shafrir, E., Birkhauser, Boston, pp.113-122.
10. Meral I, Yener Z, Kahraman T and Mert N (2001). Effect of nigella sativa on glucose concentration, lipid peroxidation antioxidant defense system and liver damage in experimentally induced diabetic rabbits. J. Vet. Med. A. Physiol. Pathol. Clin. Med., 48(10): 593-599.
11. Munday R (1988). Dialuric acid autoxidation. Effects of transition metals on the reaction rate and on the generation of "active oxygen" species. Biochem. Pharmacol., 37(3): 409-413.
12. Murugan P and Pari L (2007). Influence of Tetrahydrocurcumin on Hepatic and Renal Functional Markers and Protein Levels in Experimental Type 2 Dibetic Rats. Basic Clin. Pharmacol. Toxicol., 101(4): 241-245.
13. Sakurai K and Ogiso T (1995). Effect of ferritin on Lambda DNA strand breaks in the reaction system of alloxan plus NADPH cytochrome P450 reductase: Ferritin's role in diabetogenic action of alloxan. Biol. Pharm. Bull., 18: 262-266.
14. Seo K, Choi MS, Jung UJ, Kim HJ, Yeo J, Jeon SM and Lee MK (2008). Effect of curcumin supplementation on blood glucose, plasma insulin and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res., 52(9): 995-1004.
15. Szkudelski T, Kandulska K and Okulicz M (1998). Alloxan in vivo does not only exert deleterious effects on pancreatic beta cells. Physiol Res., 47: 343-346.
16. Takasun N, Asawa T, Komiya I, Nagasawa Y and Yamada T (1991). Alloxan-induced DNA strand breaks in pancreatic islets. J. Biol. Chem., 266: 2112-2114.
17. Tierney LM, McPhee SJ and Papadakis MA (2002). Current medical Diagnosis & Treatment. International edition, N.Y: Lange Medical Books, McGraw-Hill, pp. 1203-1215.
18. Yali Z, Meifang X, Gang N and Huanran T (2005). Mechanism of oleic acid deterioration in insulin secretion: Role in pathogenesis of type 2 diabetes. Life Sci., 77: 2071-2081.
19. Zhang X, Liang W, Mao Y, Li H, Yang Y and Tan H (2009). Hepatic glucokinase activity is the primary defect in alloxan induced diabetes of mice. Bio. Med. Pharmacotherapy, 63: 180-186.